_Sequencing_Market.webp)
Single-molecule Real-time (SMRT) Sequencing Market
Report ID: SQMIG35J2342
Report ID: SQMIG35J2342
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35J2342 |
Region:
Global |
Published Date: May, 2026
Pages:
157
|Tables:
131
|Figures:
77
Global Single-Molecule Real-Time (SMRT) Sequencing Market size was valued at USD 3.2 Billion in 2024 and is poised to grow from USD 3.57 Billion in 2025 to USD 8.66 Billion by 2033, growing at a CAGR of 11.7% during the forecast period (2026-2033).
Rising demand for long-read genomic sequencing, increasing adoption of precision medicine, growing investments in genomics research, advancements in sequencing technologies, and expanding applications in clinical diagnostics are driving sales of Single-Molecule Real-Time (SMRT) sequencing.
The lower per-read error rates and better consensus accuracy will help scientists discover genomic abnormalities such as structural variations and epigenetic patterns with greater assurance. Consequently, SMRT sequencing is becoming popular among drug development and rare diseases research companies as they try to incorporate this technology within their pipeline. With its ability to resolve highly complex genetic patterns, SMRT sequencing can help plant breeders discover genetic characteristics of crops and also help microbial scientists analyze strains. Moreover, increased partnerships within the industry and cloud bioinformatics platforms have reduced costs associated with SMRT sequencing. The ability of long, high-fidelity reads to resolve complex genomic regions that short-read platforms cannot accurately assemble is expected to primarily drive Single-Molecule Real-Time (SMRT) sequencing market growth. As sequencing costs decline and sample preparation workflows become more streamlined, adoption is expanding from specialized reference genome projects to translational research and clinical applications.
On the contrary, high costs of SMRT sequencing platforms and consumables, complex data analysis requirements, limited availability of specialized expertise, and competition from alternative sequencing technologies are anticipated to slow down Single-Molecule Real-Time (SMRT) sequencing market penetration through 2033.
How is AI Improving Accuracy And Throughput in SMRT Sequencing Technology?
AI technology will enable SMRT sequencing to achieve higher accuracy through improved data processing and analysis. AI algorithms will make data analysis faster and will help decrease the number of mistakes in sequence results. AI will contribute to more efficient basecalling and consensus polishing, helping detect more precise variants and DNA methylation marks. AI technology will also be implemented to boost the speed of data analysis and to help with optimizing sequencing runs, which will allow researchers to sequence more samples at once and will reduce the time required to analyze sequence results. AI technology will help automate the process of demultiplexing and quality control of samples. Providers of sequencing technologies are beginning to shift toward large production environments by implementing advanced AI models and GPU-accelerated analyses into their products.
Market snapshot - (2026-2033)
Global Market Size
USD 3.2 Billion
Largest Segment
Consumables & Reagents
Fastest Growth
Software & Bioinformatics Solutions
Growth Rate
11.7% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global single-molecule real-time (SMRT) sequencing market is segmented by offering, workflow, application, end user, and region. Based on offering, the market is segmented into instruments, consumables & reagents, software & bioinformatics solutions, and sequencing services. Based on workflow, the market is segmented into sample preparation & library preparation, sequencing, and data processing & analysis. Based on application, the market is segmented into whole genome sequencing, targeted sequencing, RNA sequencing & transcriptomics, epigenetics & methylation analysis, metagenomics & microbial sequencing, structural variant detection, de novo genome assembly, HLA typing & immunogenomics, rare disease & genetic disorder research, oncology research & cancer genomics, agricultural & animal genomics, drug discovery & development, and others. Based on end user, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinical laboratories, contract research organizations (CROs), government & public health laboratories, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The instruments segment is projected to spearhead the global Single-Molecule Real-Time (SMRT) sequencing market revenue generation in the future. It represents the key capital input that allows for single-molecule real-time sequencing by virtue of its proprietary optics, fluidics, and chemistry technologies, defining performance standards that dictate data quality and output. Instrument advances by vendor-driven design help reduce technical hurdles and influence lab buying behavior, while robust servicing relationships and collaborations build trust over time. These considerations foster intense investments in instruments and facilitate ecosystem evolution.
However, consumables & reagents are emerging as the fastest growing segment as per this Single-Molecule Real-Time (SMRT) sequencing industry analysis. A need for repeated reagents and innovative chemistry increase the use of the reagents as well as recurring revenues, motivating reagent manufacturers to innovate more rapidly and streamline their supply process. Growth through increased addressability, instrument utilization, and business opportunities.
The sequencing segment is forecasted to account for the highest global Single-Molecule Real-Time (SMRT) sequencing market share going forward. It offers the fundamental generation of reads and signal acquisition needed to define the utility of single molecule real time sequencing technologies across applications, where sequencing instrument chemistry and detection algorithms impact read lengths and native DNA base modifications. The improvements made to both sequencing chemistry and instrument hardware provide high-fidelity raw data for complex applications, making these technologies appealing to scientists interested in long-read analysis.
On the other hand, data processing & analysis segment is expanding at a rapid CAGR, thanks to the power of algorithms and machine learning that make sense out of SMRT’s data. The need for easy-to-use bioinformatics software and effective analytics drives the adoption and adds more benefits from the use of long reads data.
To get detailed segments analysis, Request a Free Sample Report
Scientific concentration, commercial leadership, and well-established clinical translation pathways are helping this region lead adoption of advanced Single-Molecule Real-Time (SMRT) sequencing solutions. Most leading instrument manufacturers and services providers are based in North America, which results in rapid development cycles, extensive distribution networks, and comprehensive customer support across North America. Additionally, many academic medical centers and private research institutes operate at high volumes and thus develop significant expertise in the application of long-read sequencing technology. Furthermore, many industry and translational research programs are in collaboration with each other to ensure the validation and widespread use of SMRT technology in genomics, rare disease research, and biopharmaceutical pipelines. In addition, regulatory and reimbursement frameworks related to genomics applications are more mature and sophisticated than those that are currently available in other regions. Also, the current climate for venture capital and corporate investments in North America supports continuing investment in innovations and the expansion of these innovations into commercial markets until they reach critical mass.
Single-molecule Real-time (SMRT) sequencing market in the United States benefits from a dense concentration of research hospitals, flagship universities, and commercial laboratories that drive high demand for advanced long-read capabilities. Well-established commercial ecosystems ensure full support in terms of training, maintenance, and bioinformatics services. Major instrument suppliers and vendors facilitate the availability of SMRT systems and processes. High translational research activities and collaboration between academia and the biopharmaceutical industry hasten the use of SMRT sequencing technology in drug development, clinical genomics, and variant analysis.
Collaborative networks linking academic research centers, provincial health systems, and specialized sequencing cores are helping support Single-Molecule Real-Time (SMRT) sequencing demand in Canada. Collaboration with industry supports technology transfer and local service provision. The availability of skilled technical staff and a focus on data sharing contribute to market development efforts. Research centers supported by public funds and translational units focus on the development of precision medicine efforts which are heavily reliant on long-read sequencing approaches. Core facilities offer SMRT sequencing technology to academic and clinical researchers.
Policy support, scientific excellence, and growing commercial engagement around long-read sequencing are helping generate new opportunities in the region. Research centers and national genomic initiatives focus on using technologies that provide full-resolution data about complex genomes, structural variants, and full-length transcript isoforms. This has created an increased demand for SMRT technology throughout Europe. The creation of cross-border collaborations and/ or consortia has enabled large-scale collaborative projects to be undertaken, as well as developing standardized metrics across different research institutions in Europe which also enhances the scalability of the SMRT platform when entering new markets. Many supply chains are being strengthened due to the development of local manufacturing and distribution partnerships, whilst also supporting the establishment of new academic spinouts and biotechnology companies that utilize long-read technologies for diagnostic and discovery purposes. The evolving regulatory pathways and early-stage clinical pilot projects are also adjusting to support the use of advanced sequencing technologies, allowing them to be used in translational and clinical applications.
Strong industrial biotechnology capabilities, advanced automation expertise, and well-funded research institutions are helping shape Single-Molecule Real-Time (SMRT) sequencing demand in Germany. The increased interest shown by diagnostic and pharmaceutical industries to perform complete sequencing further ensures its adoption. Strong laboratory infrastructure and emphasis on precision applications bode well for the future of the market. German Life Sciences Clusters will facilitate the use of SMRT technology in High Throughput environments as well as translational research. The synergies between technical universities and industry ensure optimization and application of technology.
Single-molecule Real-time (SMRT) sequencing market in United Kingdom is anchored by a mature genomic medicine ecosystem that supports both discovery science and clinical implementation. National health and research infrastructures enable coordinated sequencing initiatives and rapid translation of long-read technologies into diagnostic and research workflows. A strong base of geneticists, bioinformaticians, and translational researchers fosters method development and validation for complex genomic analyses. Collaborative networks between hospitals, universities, and industry accelerate pilot studies and commercialization, establishing the country as a central node for SMRT sequencing activity in Europe.
Targeted investments in genomics infrastructure, regional biotech clusters, and translational research programs are helping boost demand for Single-Molecule Real-Time (SMRT) sequencing in France. Bridging public sector institutions with their private sector counterparts through enhanced collaborations and targeted training will help build a national ecosystem for SMRT sequencing. There is increasing adoption of long-read technologies by clinical research institutes and teaching hospitals to overcome gaps in rare diseases diagnostic testing and cancer diagnostics. Local biotechnology companies and university spinoffs have been researching the use of SMRT technology in molecular diagnostics and drug development.
National strategic initiatives, expanding local manufacturing capabilities, and deepening scientific expertise in long-read sequencing applications are helping generate new business scope in Asia Pacific. The government and private sector are both placing genomics as a health care and innovation priority, which is driving infrastructure building (including data management) as well as investments in training technical staff. Domestic life sciences companies and service laboratories are employing SMRT technology platforms and developing workflows that are specifically suited for their clinical and agricultural markets. In addition to strong digital and computational capabilities, bioinformatics and large data analysis capabilities have been created to support these processes; in addition, technology-transfer initiatives are being accelerated via cross-border collaborations with established industrial partners. This will help improve market access, create local supply chains, and continue to support the Asia Pacific region as a significant contributor to the global deployment of SMRT sequencing technology.
Single-molecule Real-time (SMRT) sequencing market in Japan benefits from a strong culture of precision engineering, advanced clinical research infrastructure, and emphasis on translational medicine. Development of bioinformatics expertise and training of personnel are critical in achieving widespread adoption of long-read sequencing technology. Long-read sequencing is being incorporated into programs that focus on complex diseases in hospitals and research organizations. Local collaboration between local instrumentation providers, service providers, and academic institutions is helping to adapt SMRT protocols and maintain a high level of technical standards.
Rapid clinical adoption, strong information technology infrastructure, and an active biotech startup scene are helping boost Single-Molecule Real-Time (SMRT) sequencing innovation in South Korea. Policies favoring health care innovations along with an able technical workforce further bolster market strength and technological diffusion. Growing interest can be seen in hospitals and diagnostic laboratories using long-read sequencing to improve genomics diagnostics and personalized medicine programs. Collaboration between local firms and research organizations focuses on improving SMRT technologies and their integration with data analysis software.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Demand For Long Read Accuracy
Expanded Applications In Clinical Research
High Capital Investment Requirements
Complex Data Analysis Requirements
Request Free Customization of this report to help us to meet your business objectives.
Competitive dynamics in the global SMRT sequencing market are defined by technology differentiation and strategic consolidation, as Illumina’s proposed acquisition of Pacific Biosciences was blocked by regulators, PacBio advanced platform capacity while signing a development agreement with Invitae, and Roche completed an acquisition of a sequencing startup to broaden its portfolio. These concrete moves are accelerating competition around accuracy and scale.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, demand for long-read genomic sequencing, increasing adoption of precision medicine, growing investments in genomics research, and expanding applications in clinical diagnostics are anticipated to drive the demand for Single-Molecule Real-Time (SMRT) sequencing going forward. However, high costs of SMRT sequencing platforms and consumables, complex data analysis requirements, and competition from alternative sequencing technologies are slated to slow down the adoption of Single-Molecule Real-Time (SMRT) sequencing in the future. North America is slated to spearhead the demand for Single-Molecule Real-Time (SMRT) sequencing owing to strong investments in genomics research, widespread adoption of advanced sequencing technologies, and the presence of leading biotechnology and pharmaceutical companies. Development of AI-powered consensus polishing tools, advancements in HiFi long-read sequencing chemistry, and increasing integration of cloud-based genomic analysis platforms are anticipated to be key trends driving the Single-Molecule Real-Time (SMRT) sequencing market in the long run.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 3.2 Billion |
| Market size value in 2033 | USD 8.66 Billion |
| Growth Rate | 11.7% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Single-molecule Real-time (SMRT) Sequencing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Single-molecule Real-time (SMRT) Sequencing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Single-molecule Real-time (SMRT) Sequencing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Single-molecule Real-time (SMRT) Sequencing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Single-Molecule Real-Time (Smrt) Sequencing Market size was valued at USD 3.2 Billion in 2024 and is poised to grow from USD 3.57 Billion in 2025 to USD 8.66 Billion by 2033, growing at a CAGR of 11.7% during the forecast period (2026-2033).
Competitive dynamics in the global SMRT sequencing market are defined by technology differentiation and strategic consolidation, as Illumina’s proposed acquisition of Pacific Biosciences was blocked by regulators, PacBio advanced platform capacity while signing a development agreement with Invitae, and Roche completed an acquisition of a sequencing startup to broaden its portfolio. These concrete moves are accelerating competition around accuracy and scale. 'Pacific Biosciences', 'Illumina', 'Oxford Nanopore Technologies', 'Thermo Fisher Scientific', 'BGI Genomics', 'QIAGEN', 'Roche', 'Agilent Technologies', 'Revvity', 'Standard BioTools', 'Takara Bio', 'Azenta Life Sciences', 'GeneDx', 'Novogene', 'Macrogen', 'GenScript Biotech', 'Psomagen', 'CD Genomics', 'SeqMatic', 'Genewiz'
SMRT sequencing’s ability to generate long, highly accurate reads addresses critical needs in resolving complex genomic regions, identifying structural variants, and enabling comprehensive epigenetic profiling, which traditional short read methods struggle to deliver. This capability makes SMRT technology a preferred choice for researchers and clinical laboratories focused on difficult-to-sequence targets, driving demand for instruments, workflows, and support services. As stakeholders prioritize data completeness and interpretability, procurement decisions and research project designs increasingly favor SMRT platforms, fostering ecosystem growth and greater emphasis on platform development and application expansion.
Expanded Clinical Research Applications: Adoption of SMRT sequencing is broadening beyond basic genomics into translational and clinical research domains, driven by its ability to resolve long reads, epigenetic marks, and complex structural variants. Institutions are integrating SMRT for biomarker discovery, rare disease diagnosis, and pharmacogenomics, enabling more precise patient stratification and therapeutic development. Collaboration between clinical labs and research centers is accelerating method validation and protocol standardization, increasing demand for turnkey platforms and support services that streamline clinical deployment and downstream implementation support services.
Why does North America Dominate the Global Single-molecule Real-time (SMRT) Sequencing Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
